| Document Date: 2014-06-09 18:06:39
Open Document File Size: 40,60 KBShare Result on Facebook
Company Winston Pharmaceuticals Winston / Winston Pharmaceuticals Inc. / Winston Laboratories Inc. / / Country United States / Canada / / Event FDA Phase / / IndustryTerm pain management / latestage products / chemical name / Treatment of Osteoarthritis / treatment of the signs and symptoms / pharmaceutical / / MedicalCondition inflammatory bowel disease / arthritis / cluster headache / rheumatoid arthritis / diabetic radiculopathy / Crohn’s disease / episodic cluster headache / osteoarthritis / pain / chronic daily headache / mild-to-moderate joint pain / inflammation / postherpetic neuralgia / Osteoarthritis Osteoarthritis / / MedicalTreatment adjunctive therapy / pain management / / Organization Therapeutics Drug Directorate / CIVANEX / European Union / / Person Joel E. Bernstein / / Position President and CEO / worldwide leader in pain management / / Product acetaminophen / ibuprofen / Tylenol / Motrin / Advil / CIVANEX ™ / CIVANEX™ / / ProvinceOrState Illinois / / Region Western Ontario / /
SocialTag |
Microsoft Word - Winston Pharmaceuticals July 20 Press Release draft - NOC.doc